These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2838792)

  • 1. The biochemical and immunohistochemical profile of thyroid neoplasia.
    Stanta G; Carcangiu ML; Rosai J
    Pathol Annu; 1988; 23 Pt 1():129-57. PubMed ID: 2838792
    [No Abstract]   [Full Text] [Related]  

  • 2. Apolipoprotein e expression in anaplastic thyroid carcinoma.
    Ito Y; Takano T; Miyauchi A
    Oncology; 2006; 71(5-6):388-93. PubMed ID: 17690558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of lectin binding in benign and malignant thyroid nodules.
    Sasano H; Rojas M; Silverberg SG
    Arch Pathol Lab Med; 1989 Feb; 113(2):186-9. PubMed ID: 2916907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation.
    Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
    Hum Pathol; 2008 Nov; 39(11):1656-63. PubMed ID: 18657294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E-cadherin: a differentiation marker in thyroid malignancies.
    Brabant G; Hoang-Vu C; Cetin Y; Dralle H; Scheumann G; Mölne J; Hansson G; Jansson S; Ericson LE; Nilsson M
    Cancer Res; 1993 Oct; 53(20):4987-93. PubMed ID: 8402689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyalinizing trabecular adenoma of the thyroid gland.
    Bishop JA; Ali SZ
    Diagn Cytopathol; 2011 Apr; 39(4):306-10. PubMed ID: 20730896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential (Ha-, K- and N-) ras p21 expression in benign and malignant human thyroid tumors: an immunohistochemical study.
    Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Nakamura S; Hashimoto T
    Anticancer Res; 1995; 15(3):755-9. PubMed ID: 7645954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A unique simultaneous occurrence of paratracheal granular cell tumor and papillary thyroid carcinoma.
    Colella R; Sidoni A; Bellezza G; Cavaliere A
    Int J Surg Pathol; 2007 Jan; 15(1):82-5. PubMed ID: 17172506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma: a note of caution.
    Sahoo S; Hoda SA; Rosai J; DeLellis RA
    Am J Clin Pathol; 2001 Nov; 116(5):696-702. PubMed ID: 11710686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study of the expression of S-100 protein, epithelial membrane antigen, cytokeratin and carcinoembryonic antigen in thyroid lesions.
    Mitselou A; Vougiouklakis TG; Peschos D; Dallas P; Boumba VA; Agnantis NJ
    Anticancer Res; 2002; 22(3):1777-80. PubMed ID: 12168868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p63 expression in solid cell nests of the thyroid: further evidence for a stem cell origin.
    Reis-Filho JS; Preto A; Soares P; Ricardo S; Cameselle-Teijeiro J; Sobrinho-Simões M
    Mod Pathol; 2003 Jan; 16(1):43-8. PubMed ID: 12527712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyalinizing trabecular adenoma of the thyroid gland--a report of two cases.
    Lewy-Trenda I; Wierzchniewska-Lawska A
    Pol J Pathol; 1999; 50(4):301-3. PubMed ID: 10721271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor gamma expression in follicular-patterned thyroid lesions. Caveats for the use of immunohistochemical studies.
    Gustafson KS; LiVolsi VA; Furth EE; Pasha TL; Putt ME; Baloch ZW
    Am J Clin Pathol; 2003 Aug; 120(2):175-81. PubMed ID: 12931546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroglobulin and other soluble thyroid iodoproteins in papillary carcinoma and follicular adenoma: properties and biosynthesis in vitro.
    Sinadinović J; Mićić JV; Kraincanić M
    Endokrinologie; 1980 Oct; 76(2):143-51. PubMed ID: 6778691
    [No Abstract]   [Full Text] [Related]  

  • 15. The expression and role of serum response factor in papillary carcinoma of the thyroid.
    Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS
    Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical study of type-1 blood antigen expressions in thyroid tumors: the significance for papillary carcinomas.
    Kamoshida S; Ogane N; Yasuda M; Muramatsu T; Bessho T; Kajiwara H; Osamura RY
    Mod Pathol; 2000 Jul; 13(7):736-41. PubMed ID: 10912932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delta Np73 expression in thyroid neoplasms originating from follicular cells.
    Ito Y; Uramoto H; Funa K; Yoshida H; Jikuzono T; Asahi S; Higashiyama T; Tomoda C; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
    Pathology; 2006 Jun; 38(3):205-9. PubMed ID: 16753740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of galectin 3 expression in thyroid aspirates as a diagnostic marker in differentiating benign from malignant thyroid neoplasms.
    Aron M; Kapila K; Verma K
    Indian J Pathol Microbiol; 2006 Jul; 49(3):376-80. PubMed ID: 17001889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gas chromatographic analysis of the fatty acids in thyroid lipids in normal conditions and in various thyroid diseases and in thyroid neoplasms].
    Notario A; Bobbio Pallavicini E; Marciano S ; Bobbio Pallavicini F
    Minerva Med; 1971 Oct; 62(78):3734-46. PubMed ID: 5098136
    [No Abstract]   [Full Text] [Related]  

  • 20. Thyroid transcription factor-1 in normal, hyperplastic, and neoplastic follicular thyroid cells examined by immunohistochemistry and nonradioactive in situ hybridization.
    Katoh R; Kawaoi A; Miyagi E; Li X; Suzuki K; Nakamura Y; Kakudo K
    Mod Pathol; 2000 May; 13(5):570-6. PubMed ID: 10824930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.